The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York RFK Jr. and the Perils of Peptides Washington Monthly A Retail Explosion of Unapproved Peptides, Research Chemicals, and PEDs FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law